✦ LIBER ✦

Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer

✍ Scribed by Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miyazaki; Shigeru Hosoki; Maki Nagata; Kunio Yamaguchi

Book ID: 108978001
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 133 KB
Volume: 16
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2009.02341.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent docetaxel therapy with estr

Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Combination chemotherapy with weekly doc

Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients

✍ Atsushi Takenaka; Yuji Yamada; Toshifumi Kurahashi; Hideo Soga; Hideaki Miyake; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Treatment of androgen-independent, hormo

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

✍ Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 210 KB

Safety and efficacy of docetaxel, estram

Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients

✍ Yoshihiro Nakagami; Makoto Ohori; Noboru Sakamoto; Shoji Koga; Riu Hamada; Tadas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi